PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
27.21%
Some net income increase while MCHP is negative at -8.35%. John Neff would see a short-term edge over the struggling competitor.
0.68%
Some D&A expansion while MCHP is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
1300.00%
Some yoy growth while MCHP is negative at -110.73%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
579.12%
Well above MCHP's 54.38% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
-126.67%
Both reduce yoy inventory, with MCHP at -682.75%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
718.42%
Growth well above MCHP's 142.57%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-114.77%
Negative yoy while MCHP is 26.90%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
70.49%
Some CFO growth while MCHP is negative at -11.45%. John Neff would note a short-term liquidity lead over the competitor.
12.64%
CapEx growth well above MCHP's 19.55%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-30.03%
Both yoy lines negative, with MCHP at -147.26%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-10.17%
We reduce yoy sales while MCHP is 415.64%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
3150.00%
We have some outflow growth while MCHP is negative at -123.96%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-410.24%
We reduce yoy invests while MCHP stands at 116.65%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-55.61%
Both yoy lines negative, with MCHP at -40.93%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-89.89%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.